WLY - John Wiley & Sons, Inc.

Wiley Equips the World's Laboratories with Intelligence to Identify Substances Faster and Decide with Confidence

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today released the Wiley Registry of Mass Spectral Data 2026. As AI-driven research pipelines become standard practice across pharmaceuticals, materials science and forensic investigation, the quality of reference data underpinning those pipelines determines whether results are trusted—or stall at the verifica.

May 21, 2026 04:00 AM • businesswire.com

Wiley Names Jessica Kowalski Executive Vice President and General Manager, Research

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the appointment of Jessica Kowalski as Executive Vice President and General Manager, Research, effective May 11, 2026. She succeeds Jay Flynn, who shaped Wiley's Research business during his tenure and is leaving the company. Kowalski joins Wiley from Microsoft, bringing more than two decades of experience leading knowledge, data, research publishing, and AI-ena.

May 06, 2026 04:30 AM • businesswire.com

Scholastic vs. Wiley: Which Publishing Stock Is the Better Buy?

SCHL's transformation, Book Fairs momentum and digital push drive growth, while WLY expands through recurring revenues and rising AI-led research demand.

Apr 24, 2026 07:45 AM • zacks.com

Best Value Stocks to Buy for April 23rd

ILPT, WLY and ZTO made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 23rd, 2026.

Apr 23, 2026 03:06 AM • zacks.com

John Wiley & Sons (WLY) Upgraded to Strong Buy: Here's What You Should Know

John Wiley & Sons (WLY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Apr 17, 2026 09:00 AM • zacks.com

Best Value Stocks to Buy for April 17th

MMS, BFH and WLY made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 17th, 2026.

Apr 17, 2026 06:21 AM • zacks.com

New Strong Buy Stocks for April 17th

TPL, LNNGY, KTB, RRBI and WLY have been added to the Zacks Rank #1 (Strong Buy) List on April 17, 2026.

Apr 17, 2026 02:45 AM • zacks.com

Is Smithfield Foods, Inc. (SFD) Outperforming Other Consumer Staples Stocks This Year?

Here is how Smithfield Foods, Inc. (SFD) and John Wiley & Sons (WLY) have performed compared to their sector so far this year.

Apr 16, 2026 06:41 AM • zacks.com

Are Consumer Staples Stocks Lagging Smithfield Foods, Inc. (SFD) This Year?

Here is how Smithfield Foods, Inc. (SFD) and John Wiley & Sons (WLY) have performed compared to their sector so far this year.

Mar 31, 2026 06:41 AM • zacks.com

Wiley Announces Quarterly Dividend; Allocated $126 million to Dividends and Repurchases in 9 Months of Fiscal 2026

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.355 per share on its Class A and Class B Common Stock, payable on April 23, 2026, to shareholders of record on April 7, 2026. The quarterly dividend is equivalent to an annual dividend of $1.42 per share, an increase from.

Mar 26, 2026 03:30 AM • businesswire.com

Clarkston Capital Partners LLC Has $89.35 Million Holdings in John Wiley & Sons, Inc. $WLY

Clarkston Capital Partners LLC lifted its position in shares of John Wiley and Sons, Inc. (NYSE: WLY) by 16.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,207,824 shares of the company's stock after purchasing an additional 315,329 shares during

Mar 09, 2026 01:01 AM • defenseworld.net

John Wiley & Sons Q3 Earnings Call Highlights

John Wiley and Sons (NYSE: WLY) executives said fiscal third-quarter results were "fully in line" with expectations as the company navigated an unfavorable comparison in research and softer market conditions in learning, while pointing to continued momentum in research publishing, expanding AI-related revenue, and ongoing margin and cash flow improvement. President and CEO Matt Kissner opened

Mar 07, 2026 08:02 PM • defenseworld.net

John Wiley & Sons (NYSE:WLY) Shares Gap Up After Strong Earnings

Shares of John Wiley and Sons, Inc. (NYSE: WLY - Get Free Report) gapped up before the market opened on Thursday following a stronger than expected earnings report. The stock had previously closed at $30.45, but opened at $33.01. John Wiley and Sons shares last traded at $33.44, with a volume of 291,701 shares trading hands.

Mar 05, 2026 08:51 PM • defenseworld.net

John Wiley & Sons, Inc. (WLY) Q3 2026 Earnings Call Transcript

John Wiley & Sons, Inc. (WLY) Q3 2026 Earnings Call Transcript

Mar 05, 2026 07:45 AM • seekingalpha.com

AI Momentum, Material Margin Expansion, and Cash Flow Growth Highlight Wiley's Third Quarter 2026

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the third quarter ended January 31, 2026. THIRD QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $410 million up 1%; Operating Income of $63 million up 21%; and Diluted Earnings Per Share (EPS) of $0.56 compared to prior year loss of ($0.43) Adjusted Results at constant c.

Mar 05, 2026 02:30 AM • businesswire.com

Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley's trusted scientific and medical content into OpenEvidence. Through the partnership, physicians using OpenEvidence at the point of care can rely on content from hundreds of Wil.

Mar 03, 2026 03:00 AM • businesswire.com

Wiley Schedules Third Quarter 2026 Earnings Release and Conference Call

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY and WLYB), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its third quarter 2026 results prior to market open on Thursday March 5, 2026. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at http://events.q4inc.com/attendee/46.

Feb 26, 2026 02:30 AM • businesswire.com

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?

Feb 23, 2026 07:46 AM • zacks.com

John Wiley & Sons: Structural Risk To Higher Education Casts A Shadow Over AI Licensing

John Wiley & Sons delivers solid margin improvement and research sales growth, aided by high-margin AI licensing revenues. WLY faces structural headwinds in its learning segment due to weak white-collar job markets and potential long-term enrollment declines from LLM disruption. Despite mixed segment performance, WLY maintains strong FCF generation, robust buybacks, and a combined yield near 13% after recent price declines.

Feb 18, 2026 10:00 AM • seekingalpha.com

Wiley to Expand Prestigious Advanced Journals Portfolio

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley to significantly expand the Advanced Portfolio into life, health, and social sciences disciplines, launching eight new journals in 2026.

Feb 17, 2026 02:00 AM • businesswire.com